日本調剤（3341）のセグメントごとの売上高・利益等
セグメント通期
- 【有報】
- セグメント情報等、連結財務諸表
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医療従事者派遣・紹介事業 |
|---|---|---|---|---|
| 売上高 | 2013/03 | 1311億 | 53.3億 | 30.9億 |
| 2014/03 | 1460億 +11.4% | 155億 +190.7% | 39億 +26.5% | |
| 2015/03 | 1580億 +8.2% | 183億 +18.4% | 55.2億 +41.3% | |
| 2016/03 | 1909億 +20.8% | 204億 +11% | 80.2億 +45.4% | |
| 2017/03 | 1893億 -0.8% | 242億 +18.8% | 99.7億 +24.3% | |
| 2018/03 | 2052億 +8.4% | 247億 +2.1% | 114億 +14.4% | |
| 2019/03 | 2086億 +1.7% | 242億 -1.8% | 128億 +12.6% | |
| 2020/03 | 2310億 +10.7% | 249億 +2.8% | 126億 -1.7% | |
| 2021/03 | 2441億 +5.7% | 265億 +6.5% | 83.5億 -33.9% | |
| 2022/03 | 2656億 +8.8% | 268億 +1% | 69.8億 -16.4% | |
| 2023/03 | 2802億 +5.5% | 251億 -6.3% | 80.5億 +15.4% | |
| 2024/03 | 3028億 +8.1% | 276億 +10.1% | 98.7億 +22.6% | |
| 2025/03 | 3220億 +6.3% | 274億 -0.9% | 112億 +13.2% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医療従事者派遣・紹介事業 |
| 営業利益 | 2013/03 | 67.8億 | 2.33億 | 4.5億 |
| 2014/03 | 76.7億 +13.1% | 5億 +114.6% | 7.7億 +71.1% | |
| 2015/03 | 77億 +0.3% | 18.9億 +277.6% | 12.7億 +64.4% | |
| 2016/03 | 107億 +39.1% | 26.7億 +41.3% | 16億 +26.3% | |
| 2017/03 | 95.6億 -10.7% | 17.2億 -35.6% | 17.1億 +6.9% | |
| 2018/03 | 124億 +29.8% | 11.9億 -30.5% | 18.4億 +7.7% | |
| 2019/03 | 87.1億 -29.8% | 18.9億 +57.9% | 14.8億 -19.8% | |
| 2020/03 | 97.9億 +12.4% | 13億 -31% | 18.5億 +25.2% | |
| 2021/03 | 106億 +8.2% | 23.5億 +80.6% | 7.12億 -61.5% | |
| 2022/03 | 130億 +22.9% | -0.53億 赤字 | 5.76億 -19.1% | |
| 2023/03 | 147億 +12.7% | -13.9億 赤字 | 7.58億 +31.6% | |
| 2024/03 | 152億 +3.6% | 2.5億 | 9.37億 +23.6% | |
| 2025/03 | 134億 -11.5% | -6.3億 赤字 | 9.37億 ±0% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医療従事者派遣・紹介事業 |
| 営業利益率 | 2013/03 | 5.2% | 4.4% | 14.6% |
| 2014/03 | 5.3% +0.1% | 3.2% -1.2% | 19.7% +5.1% | |
| 2015/03 | 4.9% -0.4% | 10.3% +7.1% | 23% +3.3% | |
| 2016/03 | 5.6% +0.7% | 13.1% +2.8% | 19.9% -3.1% | |
| 2017/03 | 5% -0.6% | 7.1% -6% | 17.2% -2.7% | |
| 2018/03 | 6% +1% | 4.8% -2.3% | 16.1% -1.1% | |
| 2019/03 | 4.2% -1.8% | 7.8% +3% | 11.5% -4.6% | |
| 2020/03 | 4.2% ±0% | 5.2% -2.6% | 14.7% +3.2% | |
| 2021/03 | 4.3% +0.1% | 8.9% +3.7% | 8.5% -6.2% | |
| 2022/03 | 4.9% +0.6% | -0.2% 赤字 | 8.3% -0.2% | |
| 2023/03 | 5.2% +0.3% | -5.5% 赤字 | 9.4% +1.1% | |
| 2024/03 | 5% -0.2% | 0.9% | 9.5% +0.1% | |
| 2025/03 | 4.2% -0.8% | -2.3% 赤字 | 8.4% -1.1% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医療従事者派遣・紹介事業 |
| 研究開発費 | 2013/03 | - | - | - |
| 2014/03 | - | - | - | |
| 2015/03 | - | - | - | |
| 2016/03 | - | - | - | |
| 2017/03 | - | - | - | |
| 2018/03 | - | - | - | |
| 2019/03 | - | 27.6億 | - | |
| 2020/03 | - | - | - | |
| 2021/03 | - | - | - | |
| 2022/03 | - | - | - | |
| 2023/03 | - | - | - | |
| 2024/03 | - | - | - | |
| 2025/03 | - | - | - | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医療従事者派遣・紹介事業 |
| 設備投資額 | 2013/03 | - | - | - |
| 2014/03 | - | - | - | |
| 2015/03 | - | - | - | |
| 2016/03 | - | - | - | |
| 2017/03 | - | - | - | |
| 2018/03 | - | - | - | |
| 2019/03 | 32.2億 | 15.8億 | 291百万 | |
| 2020/03 | 90億 +179.8% | 20.7億 +30.8% | 84百万 -71.1% | |
| 2021/03 | 62.9億 -30.1% | 27億 +30.5% | 98百万 +16.7% | |
| 2022/03 | 63.7億 +1.3% | 14.9億 -44.7% | 249百万 +154.1% | |
| 2023/03 | 75.4億 +18.3% | 20.3億 +36% | 79百万 -68.3% | |
| 2024/03 | 89.3億 +18.5% | 20.4億 +0.5% | 83百万 +5.1% | |
| 2025/03 | 66億 -26.1% | 23.4億 +14.8% | 119百万 +43.4% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医療従事者派遣・紹介事業 |
| 固定資産増加額 | 2013/03 | 40.8億 | 9.71億 | 7百万 |
| 2014/03 | 27.3億 -33.1% | 56.7億 +484.1% | 19百万 +171.4% | |
| 2015/03 | 32.9億 +20.2% | 87.1億 +53.6% | 27百万 +42.1% | |
| 2016/03 | 40.5億 +23.2% | 36.6億 -58% | 30百万 +11.1% | |
| 2017/03 | 42.4億 +4.7% | 187億 +411.7% | 45百万 +50% | |
| 2018/03 | 46.8億 +10.4% | 102億 -45.3% | 89百万 +97.8% | |
| 2019/03 | 32.2億 -31.3% | 15.8億 -84.6% | 291百万 +227% | |
| 2020/03 | 90億 +179.8% | 20.7億 +30.8% | 84百万 -71.1% | |
| 2021/03 | 62.9億 -30.1% | 27億 +30.5% | 98百万 +16.7% | |
| 2022/03 | 63.7億 +1.3% | 14.9億 -44.7% | 249百万 +154.1% | |
| 2023/03 | 75.4億 +18.3% | 20.3億 +36% | 79百万 -68.3% | |
| 2024/03 | 89.3億 +18.5% | 20.4億 +0.5% | 83百万 +5.1% | |
| 2025/03 | 66億 -26.1% | 23.4億 +14.8% | 119百万 +43.4% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医療従事者派遣・紹介事業 |
| 従業員数 | 2013/03 | - | - | - |
| 2014/03 | - | - | - | |
| 2015/03 | - | - | - | |
| 2016/03 | - | - | - | |
| 2017/03 | - | - | - | |
| 2018/03 | - | - | - | |
| 2019/03 | 3,168 | 680 | 227 | |
| 2020/03 | 3,686 +16.4% | 700 +2.9% | 240 +5.7% | |
| 2021/03 | 3,888 +5.5% | 733 +4.7% | 274 +14.2% | |
| 2022/03 | 4,195 +7.9% | 761 +3.8% | 255 -6.9% | |
| 2023/03 | 4,250 +1.3% | 778 +2.2% | 270 +5.9% | |
| 2024/03 | 4,395 +3.4% | 837 +7.6% | 306 +13.3% | |
| 2025/03 | 4,752 +8.1% | 838 +0.1% | 321 +4.9% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医療従事者派遣・紹介事業 |
| 平均臨時雇用人員 | 2013/03 | - | - | - |
| 2014/03 | - | - | - | |
| 2015/03 | - | - | - | |
| 2016/03 | - | - | - | |
| 2017/03 | - | - | - | |
| 2018/03 | - | - | - | |
| 2019/03 | 671 | 20 | 3 | |
| 2020/03 | 751 +11.9% | 32 +60% | 5 +66.7% | |
| 2021/03 | 790 +5.2% | 33 +3.1% | 5 ±0% | |
| 2022/03 | 722 -8.6% | 36 +9.1% | 7 +40% | |
| 2023/03 | 698 -3.3% | 36 ±0% | 9 +28.6% | |
| 2024/03 | 686 -1.7% | 38 +5.6% | 9 ±0% | |
| 2025/03 | 667 -2.8% | 41 +7.9% | 16 +77.8% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医療従事者派遣・紹介事業 |
| 資産 | 2013/03 | 662億 | 214億 | 10.9億 |
| 2014/03 | 695億 +5% | 402億 +88.2% | 12.5億 +14% | |
| 2015/03 | 711億 +2.3% | 507億 +26% | 21億 +68.8% | |
| 2016/03 | 952億 +33.9% | 541億 +6.7% | 22.9億 +8.7% | |
| 2017/03 | 942億 -1% | 756億 +39.7% | 23.4億 +2.2% | |
| 2018/03 | 931億 -1.2% | 845億 +11.8% | 38.3億 +63.9% | |
| 2019/03 | 912億 -2% | 772億 -8.6% | 47億 +22.7% | |
| 2020/03 | 1030億 +12.9% | 753億 -2.5% | 43.7億 -6.9% | |
| 2021/03 | 1067億 +3.5% | 736億 -2.3% | 36.4億 -16.8% | |
| 2022/03 | 1029億 -3.6% | 697億 -5.2% | 41.6億 +14.5% | |
| 2023/03 | 1074億 +4.4% | 711億 +2% | 39.1億 -6% | |
| 2024/03 | 1157億 +7.7% | 711億 -0.1% | 49.9億 +27.6% | |
| 2025/03 | 1184億 +2.3% | 705億 -0.8% | 54.4億 +8.9% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医療従事者派遣・紹介事業 |
| 減損損失 | 2013/03 | 2.52億 | - | - |
| 2014/03 | 2.3億 -8.7% | - | - | |
| 2015/03 | 2.39億 +3.9% | - | - | |
| 2016/03 | 2.19億 -8.4% | - | - | |
| 2017/03 | 1.71億 -21.9% | - | - | |
| 2018/03 | 3.47億 +102.9% | 1.43億 | - | |
| 2019/03 | 6.07億 +74.9% | - | - | |
| 2020/03 | 23.9億 +293.7% | 2.72億 | - | |
| 2021/03 | 8.07億 -66.2% | 11.1億 +308.8% | - | |
| 2022/03 | 6.69億 -17.1% | - | - | |
| 2023/03 | 24.6億 +268.2% | 1.11億 | - | |
| 2024/03 | 32.3億 +30.9% | 11.7億 +950.5% | - | |
| 2025/03 | 41.3億 +28.1% | - | - | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医療従事者派遣・紹介事業 |
| のれん | 2013/03 | 77.2億 | - | - |
| 2014/03 | 83.4億 +8% | 925百万 | - | |
| 2015/03 | 78.3億 -6.1% | 827百万 -10.6% | - | |
| 2016/03 | 77.8億 -0.7% | 730百万 -11.7% | - | |
| 2017/03 | 140億 +79.7% | 632百万 -13.4% | - | |
| 2018/03 | 149億 +6.5% | 534百万 -15.5% | - | |
| 2019/03 | 141億 -5.2% | 436百万 -18.4% | - | |
| 2020/03 | 167億 +18% | 338百万 -22.5% | - | |
| 2021/03 | 161億 -3.4% | 240百万 -29% | 174百万 | |
| 2022/03 | 149億 -7.3% | 142百万 -40.8% | 156百万 -10.3% | |
| 2023/03 | 140億 -6.1% | 44百万 -69% | 138百万 -11.5% | |
| 2024/03 | 128億 -8.4% | - | 120百万 -13% | |
| 2025/03 | 115億 -10.7% | - | 122百万 +1.7% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医療従事者派遣・紹介事業 |
| のれん償却額 | 2013/03 | 4.81億 | - | - |
| 2014/03 | 5.06億 +5.2% | 52百万 | - | |
| 2015/03 | 5.46億 +7.9% | 97百万 +86.5% | - | |
| 2016/03 | 5.65億 +3.5% | 97百万 ±0% | - | |
| 2017/03 | 8.78億 +55.4% | 97百万 ±0% | - | |
| 2018/03 | 12.3億 +39.9% | 97百万 ±0% | - | |
| 2019/03 | 13.9億 +13.1% | 97百万 ±0% | - | |
| 2020/03 | 14.8億 +6.8% | 97百万 ±0% | - | |
| 2021/03 | 16.6億 +11.9% | 97百万 ±0% | 4百万 | |
| 2022/03 | 17億 +2.3% | 97百万 ±0% | 17百万 +325% | |
| 2023/03 | 18.4億 +8.1% | 97百万 ±0% | 17百万 ±0% | |
| 2024/03 | 18.3億 -0.4% | 44百万 -54.6% | 17百万 ±0% | |
| 2025/03 | 18.9億 +3.3% | - | 20百万 +17.6% |
セグメント四半期
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
|---|---|---|---|---|---|---|
| 調剤薬局事業 | ||||||
| 売上高 1Q2Q 3Q | 2014/03 | 350億 | 358億 | 378億 | 374億 | 1460億 |
| 2015/03 | 375億 +7.1% | 384億 +7.4% | 409億 +8.2% | 412億 +10.2% | 1580億 +8.2% | |
| 2016/03 | 423億 +12.7% | 449億 +16.8% | 506億 +24% | 530億 +28.8% | 1909億 +20.8% | |
| 2017/03 | 459億 +8.5% | 464億 +3.4% | 484億 -4.4% | 486億 -8.4% | 1893億 -0.8% | |
| 2018/03 | 494億 +7.6% | 506億 +9.1% | 528億 +9% | 524億 +7.9% | 2052億 +8.4% | |
| 2019/03 | 504億 +2.2% | 506億 ±-0% | 546億 +3.5% | 529億 +1% | 2086億 +1.7% | |
| 2020/03 | 548億 +8.7% | 569億 +12.5% | 589億 +7.8% | 603億 +14% | 2310億 +10.7% | |
| 2021/03 | 582億 +6.2% | 600億 +5.4% | 629億 +6.7% | 629億 +4.4% | 2441億 +5.7% | |
| 2022/03 | 629億 +8.1% | 658億 +9.7% | 686億 +9.1% | 682億 +8.4% | 2656億 +8.8% | |
| 2023/03 | 664億 +5.5% | 698億 +6% | 719億 +4.7% | 721億 +5.6% | 2802億 +5.5% | |
| 2024/03 | 723億 +8.9% | 753億 +7.9% | 780億 +8.4% | 772億 +7.1% | 3028億 +8.1% | |
| 営業利益 1Q2Q 3Q | 2014/03 | 17.5億 | 18.7億 | 21.7億 | 18.8億 | 76.7億 |
| 2015/03 | 11.9億 -32.1% | 19.2億 +2.9% | 23.1億 +6.3% | 22.8億 +21.2% | 77億 +0.3% | |
| 2016/03 | 20.2億 +69.3% | 22.4億 +16.3% | 29億 +25.5% | 35.6億 +56.2% | 107億 +39.1% | |
| 2017/03 | 14.8億 -26.8% | 25.9億 +15.7% | 26.4億 -9% | 28.6億 -19.6% | 95.6億 -10.7% | |
| 2018/03 | 25.1億 +70.2% | 31.1億 +20% | 34.3億 +30.3% | 33.6億 +17.5% | 124億 +29.8% | |
| 2019/03 | 14億 -44.1% | 17.9億 -42.3% | 28.4億 -17.3% | 26.7億 -20.5% | 87.1億 -29.8% | |
| 2020/03 | 18.4億 +31.3% | 25.7億 +43.1% | 21.7億 -23.4% | 32億 +19.9% | 97.9億 +12.4% | |
| 2021/03 | 4.64億 -74.8% | 31.6億 +23.2% | 33.7億 +54.9% | 35.9億 +12.2% | 106億 +8.2% | |
| 2022/03 | 18.9億 +306.9% | 31.5億 -0.2% | 40.7億 +20.8% | 39億 +8.5% | 130億 +22.9% | |
| 2023/03 | 20.6億 +9.2% | 39.3億 +24.7% | 46.1億 +13.3% | 40.7億 +4.2% | 147億 +12.7% | |
| 2024/03 | 29.1億 +41% | 31.1億 -20.9% | 46.1億 +0.1% | 45.6億 +12.2% | 152億 +3.6% | |
| 営業利益率 | 2014/03 | 5% | 5.2% | 5.7% | 5% | 5.3% |
| 2015/03 | 3.2% -1.8% | 5% -0.2% | 5.6% -0.1% | 5.5% +0.5% | 4.9% -0.4% | |
| 2016/03 | 4.8% +1.6% | 5% ±0% | 5.7% +0.1% | 6.7% +1.2% | 5.6% +0.7% | |
| 2017/03 | 3.2% -1.6% | 5.6% +0.6% | 5.4% -0.3% | 5.9% -0.8% | 5% -0.6% | |
| 2018/03 | 5.1% +1.9% | 6.1% +0.5% | 6.5% +1.1% | 6.4% +0.5% | 6% +1% | |
| 2019/03 | 2.8% -2.3% | 3.5% -2.6% | 5.2% -1.3% | 5% -1.4% | 4.2% -1.8% | |
| 2020/03 | 3.4% +0.6% | 4.5% +1% | 3.7% -1.5% | 5.3% +0.3% | 4.2% ±0% | |
| 2021/03 | 0.8% -2.6% | 5.3% +0.8% | 5.4% +1.7% | 5.7% +0.4% | 4.3% +0.1% | |
| 2022/03 | 3% +2.2% | 4.8% -0.5% | 5.9% +0.5% | 5.7% ±0% | 4.9% +0.6% | |
| 2023/03 | 3.1% +0.1% | 5.6% +0.8% | 6.4% +0.5% | 5.6% -0.1% | 5.2% +0.3% | |
| 2024/03 | 4% +0.9% | 4.1% -1.5% | 5.9% -0.5% | 5.9% +0.3% | 5% -0.2% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 医薬品製造販売事業 | ||||||
| 売上高 1Q2Q 3Q | 2014/03 | 37億 | 37億 | 42.2億 | 38.6億 | 155億 |
| 2015/03 | 43.6億 +17.7% | 46.3億 +25% | 46.9億 +11.2% | 46.6億 +20.5% | 183億 +18.4% | |
| 2016/03 | 47.5億 +8.9% | 46.5億 +0.5% | 57.1億 +21.6% | 52.5億 +12.7% | 204億 +11% | |
| 2017/03 | 61.3億 +29.1% | 62.3億 +33.9% | 56.6億 -0.8% | 61.7億 +17.5% | 242億 +18.8% | |
| 2018/03 | 59.9億 -2.3% | 63.8億 +2.5% | 64.9億 +14.7% | 58.2億 -5.6% | 247億 +2.1% | |
| 2019/03 | 57.3億 -4.3% | 57億 -10.7% | 67.6億 +4.1% | 60.4億 +3.8% | 242億 -1.8% | |
| 2020/03 | 59.3億 +3.4% | 58.6億 +2.8% | 68.6億 +1.5% | 62.5億 +3.5% | 249億 +2.8% | |
| 2021/03 | 72億 +21.4% | 55.8億 -4.8% | 78.3億 +14.2% | 59.2億 -5.3% | 265億 +6.5% | |
| 2022/03 | 70.4億 -2.2% | 67.7億 +21.4% | 70.4億 -10.2% | 59.4億 +0.4% | 268億 +1% | |
| 2023/03 | 62.7億 -10.9% | 59.3億 -12.4% | 66.7億 -5.3% | 62.3億 +4.9% | 251億 -6.3% | |
| 2024/03 | 69.6億 +11% | 68.1億 +14.8% | 74.5億 +11.7% | 64.1億 +2.8% | 276億 +10.1% | |
| 営業利益 1Q2Q 3Q | 2014/03 | 0.74億 | 2.08億 | 1.45億 | 0.73億 | 5億 |
| 2015/03 | 3.3億 +345.9% | 5.06億 +143.3% | 6.11億 +321.4% | 4.41億 +504.1% | 18.9億 +277.6% | |
| 2016/03 | 5.89億 +78.5% | 6.21億 +22.7% | 9.91億 +62.2% | 4.67億 +5.9% | 26.7億 +41.3% | |
| 2017/03 | 7.44億 +26.3% | 4.47億 -28% | 2.19億 -77.9% | 3.09億 -33.8% | 17.2億 -35.6% | |
| 2018/03 | 3.18億 -57.3% | 3.2億 -28.4% | 7.93億 +262.1% | -2.37億 赤字 | 11.9億 -30.5% | |
| 2019/03 | 0.59億 -81.4% | 2.85億 -10.9% | 8.41億 +6.1% | 7億 | 18.9億 +57.9% | |
| 2020/03 | 7.98億 +999.99% | 3.57億 +25.3% | 3.79億 -54.9% | -2.33億 赤字 | 13億 -31% | |
| 2021/03 | 8.33億 +4.4% | 3.3億 -7.6% | 10.4億 +174.9% | 1.45億 | 23.5億 +80.6% | |
| 2022/03 | 4.51億 -45.9% | -2.56億 赤字 | 11億 +5.5% | -13.5億 赤字 | -0.53億 赤字 | |
| 2023/03 | 2.7億 -40.1% | -6.66億 赤字 | -0.6億 赤字 | -9.36億 赤字 | -13.9億 赤字 | |
| 2024/03 | 1.26億 -53.3% | 0.41億 | 3.88億 | -3.05億 赤字 | 2.5億 | |
| 営業利益率 | 2014/03 | 2% | 5.6% | 3.4% | 1.9% | 3.2% |
| 2015/03 | 7.6% +5.6% | 10.9% +5.3% | 13% +9.6% | 9.5% +7.6% | 10.3% +7.1% | |
| 2016/03 | 12.4% +4.8% | 13.4% +2.5% | 17.4% +4.4% | 8.9% -0.6% | 13.1% +2.8% | |
| 2017/03 | 12.1% -0.3% | 7.2% -6.2% | 3.9% -13.5% | 5% -3.9% | 7.1% -6% | |
| 2018/03 | 5.3% -6.8% | 5% -2.2% | 12.2% +8.3% | -4.1% 赤字 | 4.8% -2.3% | |
| 2019/03 | 1% -4.3% | 5% ±0% | 12.4% +0.2% | 11.6% | 7.8% +3% | |
| 2020/03 | 13.5% +12.5% | 6.1% +1.1% | 5.5% -6.9% | -3.7% 赤字 | 5.2% -2.6% | |
| 2021/03 | 11.6% -1.9% | 5.9% -0.2% | 13.3% +7.8% | 2.4% | 8.9% +3.7% | |
| 2022/03 | 6.4% -5.2% | -3.8% 赤字 | 15.6% +2.3% | -22.7% 赤字 | -0.2% 赤字 | |
| 2023/03 | 4.3% -2.1% | -11.2% 赤字 | -0.9% 赤字 | -15% 赤字 | -5.5% 赤字 | |
| 2024/03 | 1.8% -2.5% | 0.6% | 5.2% | -4.8% 赤字 | 0.9% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 医療従事者派遣・紹介事業 | ||||||
| 売上高 1Q2Q 3Q | 2014/03 | 9.88億 | 9.39億 | 9.5億 | 10.3億 | 39億 |
| 2015/03 | 12.3億 +24.2% | 12.4億 +31.8% | 14.3億 +50% | 16.3億 +58.4% | 55.2億 +41.3% | |
| 2016/03 | 18.3億 +48.8% | 18.4億 +48.6% | 20.3億 +42.4% | 23.3億 +43.1% | 80.2億 +45.4% | |
| 2017/03 | 24.4億 +33.4% | 23.6億 +28.3% | 24.9億 +22.5% | 26.9億 +15.5% | 99.7億 +24.3% | |
| 2018/03 | 29.7億 +22.1% | 28億 +18.6% | 28.2億 +13.5% | 28.1億 +4.7% | 114億 +14.4% | |
| 2019/03 | 31.3億 +5.2% | 30.9億 +10.3% | 33億 +17.1% | 33.3億 +18.2% | 128億 +12.6% | |
| 2020/03 | 35.8億 +14.4% | 31.8億 +2.9% | 29.5億 -10.6% | 29.2億 -12.1% | 126億 -1.7% | |
| 2021/03 | 29.1億 -18.7% | 20.8億 -34.5% | 16.2億 -45.3% | 17.5億 -40.3% | 83.5億 -33.9% | |
| 2022/03 | 19億 -34.7% | 17.4億 -16.3% | 15.6億 -3.5% | 17.8億 +1.9% | 69.8億 -16.4% | |
| 2023/03 | 20.6億 +8.6% | 18.9億 +8.3% | 19.5億 +25% | 21.5億 +21.1% | 80.5億 +15.4% | |
| 2024/03 | 25.8億 +24.8% | 23.6億 +24.9% | 24億 +23.3% | 25.4億 +17.9% | 98.7億 +22.6% | |
| 営業利益 1Q2Q 3Q | 2014/03 | 2.83億 | 2.04億 | 1.15億 | 1.68億 | 7.7億 |
| 2015/03 | 3.27億 +15.5% | 2.92億 +43.1% | 2.76億 +140% | 3.71億 +120.8% | 12.7億 +64.4% | |
| 2016/03 | 4.41億 +34.9% | 3.79億 +29.8% | 3.07億 +11.2% | 4.72億 +27.2% | 16億 +26.3% | |
| 2017/03 | 4.4億 -0.2% | 3.68億 -2.9% | 4.17億 +35.8% | 4.85億 +2.8% | 17.1億 +6.9% | |
| 2018/03 | 6.01億 +36.6% | 4.11億 +11.7% | 4.04億 -3.1% | 4.26億 -12.2% | 18.4億 +7.7% | |
| 2019/03 | 4.01億 -33.3% | 2.29億 -44.3% | 4.26億 +5.4% | 4.22億 -0.9% | 14.8億 -19.8% | |
| 2020/03 | 6.51億 +62.3% | 4.31億 +88.2% | 3.6億 -15.5% | 4.09億 -3.1% | 18.5億 +25.2% | |
| 2021/03 | 5.09億 -21.8% | 1.87億 -56.6% | -0.43億 赤字 | 0.59億 -85.6% | 7.12億 -61.5% | |
| 2022/03 | 2.78億 -45.4% | 1.62億 -13.4% | -0.17億 赤字 | 1.53億 +159.3% | 5.76億 -19.1% | |
| 2023/03 | 3.55億 +27.7% | 1.45億 -10.5% | 1.02億 | 1.56億 +2% | 7.58億 +31.6% | |
| 2024/03 | 4.84億 +36.3% | 2.14億 +47.6% | 0.97億 -4.9% | 1.42億 -9% | 9.37億 +23.6% | |
| 営業利益率 | 2014/03 | 28.6% | 21.7% | 12.1% | 16.4% | 19.7% |
| 2015/03 | 26.7% -1.9% | 23.6% +1.9% | 19.4% +7.3% | 22.8% +6.4% | 23% +3.3% | |
| 2016/03 | 24.2% -2.5% | 20.6% -3% | 15.1% -4.3% | 20.3% -2.5% | 19.9% -3.1% | |
| 2017/03 | 18.1% -6.1% | 15.6% -5% | 16.8% +1.7% | 18.1% -2.2% | 17.2% -2.7% | |
| 2018/03 | 20.2% +2.1% | 14.7% -0.9% | 14.3% -2.5% | 15.1% -3% | 16.1% -1.1% | |
| 2019/03 | 12.8% -7.4% | 7.4% -7.3% | 12.9% -1.4% | 12.7% -2.4% | 11.5% -4.6% | |
| 2020/03 | 18.2% +5.4% | 13.6% +6.2% | 12.2% -0.7% | 14% +1.3% | 14.7% +3.2% | |
| 2021/03 | 17.5% -0.7% | 9% -4.6% | -2.7% 赤字 | 3.4% -10.6% | 8.5% -6.2% | |
| 2022/03 | 14.6% -2.9% | 9.3% +0.3% | -1.1% 赤字 | 8.6% +5.2% | 8.3% -0.2% | |
| 2023/03 | 17.2% +2.6% | 7.7% -1.6% | 5.2% | 7.2% -1.4% | 9.4% +1.1% | |
| 2024/03 | 18.8% +1.6% | 9.1% +1.4% | 4% -1.2% | 5.6% -1.6% | 9.5% +0.1% | |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
